Esperion Therapeutics reported $275.17M in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acceleron Pharma XLRN:US $ 717.77M 19.84M
Adamas Pharmaceuticals ADMS:US 115.66M 42.45M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Alnylam Pharmaceuticals ALNY:US $ 2725.16M 255.08M
Amarin AMRN:US $ 995.98M 65.47M
Amgen AMGN:US $ 19099M 2200M
Arena Pharmaceuticals ARNA:US $ 990.44M 131.17M
Biogen BIIB:US $ 7162.3M 21.4M
Biomarin Pharmaceutical BMRN:US $ 2357.84M 69.07M
Cytokinetics CYTK:US $ 364.23M 68.89M
Daiichi Sankyo 4568:JP Y 1233697M 34723M
Eli Lilly And LLY:US $ 17295.5M 691M
Esperion Therapeutics ESPR:US $ 275.17M 2.6M
Flexion Therapeutics FLXN:US $ 184.12M 20.5M
Geron GERN:US $ 201.76M 13.5M
Halozyme Therapeutics HALO:US $ 999.75M 58.03M
Heron Therapeutics HRTX:US $ 366.83M 94.54M
Intercept Pharmaceuticals ICPT:US $ 493.1M 5.54M
Intra Cellular Therapies ITCI:US $ 601.3M 47.8M
Minerva Neurosciences NERV:US $ 75.22M 6.46M
Moderna Inc MRNA:US 10.97B 734M
Nektar Therapeutics NKTR:US $ 1056.15M 42.9M
Ptc Therapeutics PTCT:US $ 1066.23M 56.13M
Puma Biotechnology PBYI:US $ 167.75M 3.99M
Regeneron Pharmaceuticals REGN:US $ 13337.6M 3282.5M
Sarepta Therapeutics SRPT:US $ 2265.22M 6.13M
Seattle Genetics SGEN:US $ 3098.51M 5.18M
United Therapeutics UTHR:US $ 2317.9M 303.6M
Vanda Pharmaceuticals VNDA:US $ 446.65M 25.43M
Zogenix ZGNX:US $ 416.39M 38.34M